<DOC>
	<DOCNO>NCT01008085</DOCNO>
	<brief_summary>Study hypothesis : Stentys self-expandable Stent result well alignment strut vessel wall balloon-expandable stent within day procedure acute myocardial infarction patient .</brief_summary>
	<brief_title>STENTYS Self-expanding Versus Balloon-expandable Stent Acute Myocardial Infarction ( AMI )</brief_title>
	<detailed_description>Stent strut malapposition stent underexpansion common phenomenon AMI result change anatomy AMI occur ( thrombus dissolution , resolution spasm ) traditional balloon-expandable stent treatment . A self-expanding stent might lead well stent strut apposition follow contour vessel wall due self-expanding property . This might result good long term clinical outcome like low thrombosis rate .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Subject 18 year old . 2 . Acute Myocardial Infarction define presence least two three item : 1 . Detection rise cardiac biomarkers least one value 99th percentile upper reference limit ( URL ) 2 . Symptoms ischaemia ( chest pain ) &gt; 20 minute 3 . ECG change indicative new ischaemia : new STT change ( ST deviation ≥0.2mV precordial lead and/or ≥0.1mV limb lead ) new LBBB ) 3 . Reperfusion expect achieve within 12 hour onset symptom 4 . Subject understands nature procedure provide write informed consent prior catheterization procedure . 5 . Subject willing comply specify followup evaluation contact telephone . 6 . Acceptable candidate coronary artery bypass graft ( CABG ) surgery . 7 . Male nonpregnant female subject . Angiographic 1 . Reference vessel diameter &gt; 2.5mm &lt; 4.0mm visual estimate . 2 . Target lesion &lt; 30mm length visual estimate 1 . Currently enrol another investigational device drug study complete primary endpoint clinically interfere current study endpoint . 2 . Coronary cardiac intervention major surgery kind within 30 day prior procedure . 3 . Target vessel supplied bypass vessel 4 . Patients anticoagulation therapy ( Coumadin ) 5 . Patient receive thrombolytic therapy . 6 . Myocardial infarction due stent thrombosis , infarct lesion side previously implant stent 7 . Cardiogenic shock 8 . Any previous stent placement within 10mm ( proximal distal ) target lesion . 9 . Comorbid condition ( ) could limit subject 's ability participate study comply followup requirement , impact scientific integrity study . 10 . Concurrent medical condition life expectancy le 6 month . 11 . Left ventricular ejection fraction ( LVEF ) &lt; 30 % recent evaluation . 12 . Cerebrovascular accident transient ischemic attack last 6 month . 13 . Known hypersensitivity contraindication aspirin , heparin bivalirudin , clopidogrel ticlopidine , cobalt , nickel , sensitivity contrast medium , adequately premedicated . 14 . Known serum creatinine level &gt; 2.5mg/dl presence history renal failure Angiographic 1 . Unprotected leave main coronary artery disease ( obstruction great 50 % leave main coronary artery protect least one nonobstructed bypass graft leave anterior descending ( LAD ) leave circumflex ( LCX ) artery branch thereof ) . 2 . Target vessel excessively tortuous ( two bend &gt; 90˚ reach target lesion ) . 3 . Lesion location aortoostial within 5mm origin LAD LCX . 4 . Target lesion severely calcify .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>STEMI</keyword>
	<keyword>self-expandable</keyword>
	<keyword>balloon-expandable</keyword>
</DOC>